RARE
Ultragenyx Pharmaceutical Inc
$14.30
-0.69% ($0.10)
Volume
3.25M
52W High
$39.89
52W Low
$13.81
Market Cap
$2.50B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.65
Whisper EPS
-$0.65
0.4% above consensus
Last Quarter
-$0.90
Current Streak
1 Beat
Avg Surprise (4Q)
+11.83%
Next Earnings Report
Reports in 49 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Aug 4, 2026
1-Day:
-3.41%
Q1 2026
May 5, 2026
1-Day:
+3.68%
Q1 2026
Apr 30, 2026
1-Day:
+0.32%
5-Day:
+1.30%
Q4 2025
Feb 12, 2026
1-Day:
-12.68%
5-Day:
-14.13%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $207.0M | +25.6% | 86.0% | -55.1% | -$129.0M |
| Q3'25 | $159.9M | +14.7% | 82.5% | -106.9% | -$180.4M |
| Q2'25 | $166.5M | +13.2% | 86.2% | -64.8% | -$115.0M |
| Q1'25 | $139.3M | +28.0% | 79.4% | -102.6% | -$151.1M |
| Q4'24 | $164.9M | +29.4% | 89.8% | -74.2% | -$133.4M |
| Q3'24 | $139.5M | +42.3% | 84.9% | -94.6% | -$133.5M |
| Q2'24 | $147.0M | +35.8% | 85.5% | -79.1% | -$131.6M |
| Q1'24 | $108.8M | +8.3% | 83.9% | -151.9% | -$170.7M |
Company Information
Symbol
RARE
Company
Ultragenyx Pharmaceutical Inc
Market Cap
$2.50B
Next Earnings
Nov 3, 2026